We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 87.860.0%Oct 23 12:00 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: bobbseytwins20019/14/2019 3:04:11 PM
12 Recommendations

Recommended By

and 7 more members

  Read Replies (5) of 58872
While a certain discriminating group on this board have been analyzing, agonizing, criticizing, second guessing, and interpreting every move by IMMU management, and imploring and demanding "execution" from Behzad, behind the scenes institutions of all sizes and disciplines have quietly accumulated 192,536,896 shares or 100.52% of the outstanding IMMU shares. [Latest data from fintel ... Google Immunomedics institutional holdings, scroll down to fintel]. Add to that 10-20 million shares held by insiders including Dave Goldenberg, who is still mostly holding, and you come up with about 110% of the outstanding shares. Obviously, even with some short covering last week shorts have still borrowed or are naked 35 million shares plus or minus. Of course we have heard from pundits here that institutions and insiders know little about how all this stock stuff works and are frequently wrong, but still it is interesting that they would be accumulating now going into a perceived make or break event i.e. the resubmission, seemingly with nearly reckless abandon. Can anyone imagine what might happen if the biotechs strengthen or good IMMU news breaks out? What if another large buyer shows up? Will their big orders be filled by market makers, the public, profit takers? More shorts?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext